Regeneron Pharmaceuticals, Inc. stock price
REGN · NMS · stock
$750.51▼ 1.74 (-0.23%)
Open
$745.15
Prev close
$752.25
Day high
$752.43
Day low
$741.83
52-wk high
$859.34
52-wk low
$541.00
P/E (TTM)
16.50×
Net margin
31.80%
Regeneron Pharmaceuticals, Inc. (REGN) is a US-listed company (NYSE / Nasdaq). Traddx shows its live price, interactive candlestick charts, quarterly financials straight from SEC filings, a Groww-style health scorecard, and support/resistance — plus Athena, our US research analyst, for a plain-English take.
Quarterly financials
| Quarter | Revenue $M | YoY | Net profit $M | EPS $ |
|---|---|---|---|---|
| Q2 2026 | 4,290.70 | +16.70% | 1,296.90 | 12.23 |
| Q1 2026 | 3,605.40 | +19.00% | 727.20 | 6.75 |
| Q3 2025 | 3,754.30 | +0.90% | 1,460.00 | 13.62 |
| Q2 2025 | 3,675.60 | +3.60% | 1,391.60 | 12.81 |
| Q1 2025 | 3,028.70 | -3.70% | 808.70 | 7.27 |
| Q3 2024 | 3,720.70 | +10.60% | 1,340.60 | 11.54 |
| Q2 2024 | 3,547.10 | +12.30% | 1,432.30 | 12.41 |
| Q1 2024 | 3,145.00 | -0.50% | 722.00 | 6.27 |
Figures in US$ millions, latest first (source: SEC filings).